Scibetta James S
President at PCRX
- Sold, on record
- $10.9M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jun 5, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PCRXPacira BioSciences, Inc.President
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PCRXUnusualAug 8, 2014 2014
Sold 15,000 shares at $99.63 ($1.5M)
Scibetta James S, SVP, Chief Financial Officer
Sold 75% of holdings ($2M position)5,000 shares left1.5x usual sizeFiling
- 2 Form 4 sale PCRXUnusualNov 7, 2014 +91 days
Sold 15,000 shares at $87.18 ($1.3M)
Scibetta James S, SVP, Chief Financial Officer
Sold 75% of holdings ($1.7M position)5,000 shares left1.5x usual sizeFiling
- 3 Form 4 sale PCRXUnusualFeb 6, 2015 +91 days
Sold 15,000 shares at $111.22 ($1.7M)
Scibetta James S, SVP, Chief Financial Officer
Sold 74.1% of holdings ($2.3M position)5,230 shares left1.5x usual sizeFiling
- 4 Form 4 sale PCRXUnusualAug 15, 2016 +556 days
Sold 25,000 shares at $45.21 ($1.1M)
Scibetta James S, President
Sold 48% of holdings ($2.4M position)27,084 shares leftFiling
- 5 Form 4 sale PCRXUnusualNov 15, 2016 +92 days
Sold 20,000 shares at $36.50 ($730k)
Scibetta James S, President
Sold 42.5% of holdings ($1.7M position)27,084 shares leftFiling
- 6 Form 4 sale PCRXUnusualJan 17, 2017 +63 days
Sold 20,000 shares at $38.53 ($771k)
Scibetta James S, President
Sold 42.5% of holdings ($1.8M position)27,084 shares left1x usual sizeFiling
- 7 Form 4 sale PCRXUnusualMay 15, 2017 +118 days
Sold 20,000 shares at $51.20 ($1M)
Scibetta James S, President
Sold 42.5% of holdings ($2.4M position)27,084 shares left1x usual sizeFiling
- 8 Form 4 sale PCRXPlan not statedJun 5, 2017 +21 days
Sold 1,966 shares at $43.32 ($85k)
Scibetta James S, President
Sold 7.3% of holdings ($1.2M position)25,118 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2017 | Jun 7, 2017 | PCRX | President | Form 4 sale | 1,966 | $85k | 7.3% | Plan not stated | SEC |
| May 15, 2017 | May 17, 2017 | PCRX | President | Form 4 sale | 20,000 | $1M | 42.5% | Unusual | SEC |
| Jan 17, 2017 | Jan 19, 2017 | PCRX | President | Form 4 sale | 20,000 | $771k | 42.5% | Unusual | SEC |
| Nov 15, 2016 | Nov 17, 2016 | PCRX | President | Form 4 sale | 20,000 | $730k | 42.5% | Unusual | SEC |
| Aug 15, 2016 | Aug 17, 2016 | PCRX | President | Form 4 sale | 25,000 | $1.1M | 48.0% | Unusual | SEC |
| Feb 6, 2015 | Feb 9, 2015 | PCRX | SVP, Chief Financial Officer | Form 4 sale | 15,000 | $1.7M | 74.1% | Unusual | SEC |
| Nov 7, 2014 | Nov 12, 2014 | PCRX | SVP, Chief Financial Officer | Form 4 sale | 15,000 | $1.3M | 75.0% | Unusual | SEC |
| Aug 8, 2014 | Aug 11, 2014 | PCRX | SVP, Chief Financial Officer | Form 4 sale | 15,000 | $1.5M | 75.0% | Unusual | SEC |
| May 8, 2014 | May 9, 2014 | PCRX | SVP, Chief Financial Officer | Form 4 sale | 15,000 | $1.1M | 75.0% | Unusual | SEC |
| Dec 30, 2013 | Jan 2, 2014 | PCRX | Chief Financial Officer | Form 4 sale | 10,000 | $556k | 66.7% | Unusual | SEC |
| Sep 30, 2013 | Oct 2, 2013 | PCRX | Chief Financial Officer | Form 4 sale | 10,000 | $467k | 66.7% | Unusual | SEC |
| Jun 28, 2013 | Jul 2, 2013 | PCRX | Chief Financial Officer | Form 4 sale | 10,000 | $281k | 66.7% | Unusual | SEC |
| Mar 28, 2013 | Apr 1, 2013 | PCRX | Chief Financial Officer | Form 4 sale | 10,000 | $285k | 66.7% | Unusual | SEC |